Cite
HARVARD Citation
Mäder, J. et al. (n.d.). PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. Thrombosis research. pp. S25-. [Online].